Intrathecal MRI Contrast for Assessment of CSF Transport

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519936-18-00

Acronym

2015/96 MRI contrast

Enrollment

400

Registered

2025-01-28

Start date

2025-01-29

Completion date

Unknown

Last updated

2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CNS neoplasia, Cognitive impairment, CSF disorders, Fatigue, Hydrocephalus

Brief summary

MRI evidence of CSF flow Blood-based determination of CSF clearance

Detailed description

Quantitative estimation of CSF flow and clearance

Interventions

DRUGGADOBUTROL

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
MRI evidence of CSF flow Blood-based determination of CSF clearance	—

Secondary

Measure	Time frame
Quantitative estimation of CSF flow and clearance	—

Countries

Norway

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026